Archive · 19 Jan 2026
Drug Quality Defines Future of Indian Pharma
Dr. Sujit Paul talks about how important it is for Indian medicines to be good quality.
He says that patients and other countries are now checking more carefully.
To make sure medicines are safe and work well, there are three important things: science, good systems, and watching for problems.
Patients want to know that medicines are good, not just cheap.
Dr. Paul believes that in the future, India should focus on proving that its medicines are trustworthy, not just making a lot of them.
Drug quality is crucial for patient trust and global reputation of Indian pharma.
Three pillars of drug quality: science, systems, and surveillance.
Patients are becoming more informed and demand proof of drug quality.
Affordability and quality can coexist through ethical practices.
Future of Indian pharma depends on validation and consistency, not just volume.
- Who
- Dr. Sujit Paul, Group CEO, Zota Healthcare Ltd.
- What
- The importance of drug quality in the Indian pharmaceutical industry
- When
- January 19, 2026
- Where
- India
- Why
- To build and maintain patient trust and global reputation
- Date
- January 19, 2026
- Author
- Dr. Sujit Paul, Group CEO, Zota Healthcare Ltd.
- Key Focus
- Drug quality and patient trust
- Three Pillars of Drug Quality
- Science, Systems, Surveillance
- Patient Expectations
- Proof, not just price
- Industry Challenge
- Balancing affordability and quality
- Future Focus
- Validation over volume